4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001628280-23-008837
Chief Medical Officer acquired 33,219 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Podnos Yale Chief Medical Officer | 2023-03-17 | Grant or award | +33,219 | 90,466 | D | ||
| Derivatives | |||||||
| Podnos Yale Chief Medical Officer | 2023-03-17 | Grant or award · Non-Qualified Stock Option (right to buy) | +83,047 | 83,047 | D | ||
Loading xslF345X04/wf-form4_167944702947968.xml…